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Background: Seminal plasma serves as a natural reservoir of antioxidants. It helps to remove excessive formation of
reactive oxygen species (ROS) and consequently, reduce oxidative stress. Proteomic profiling of seminal plasma
proteins is important to understand the molecular mechanisms underlying oxidative stress and sperm dysfunction
in infertile men.
Methods: This prospective study consisted of 52 subjects: 32 infertile men and 20 healthy donors. Once semen and
oxidative stress parameters were assessed (ROS, antioxidant concentration and DNA damage), the subjects were
categorized into ROS positive (ROS+) or ROS negative (ROS-). Seminal plasma from each group was pooled and
subjected to proteomics analysis. In-solution digestion and protein identification with liquid chromatography
tandem mass spectrometry (LC-MS/MS), followed by bioinformatics analyses was used to identify and characterize
potential biomarker proteins.
Results: A total of 14 proteins were identified in this analysis with 7 of these common and unique proteins were
identified in both the ROS+ and ROS- groups through MASCOT and SEQUEST analyses, respectively. Prolactin-
induced protein was found to be more abundantly present in men with increased levels of ROS. Gene ontology
annotations showed extracellular distribution of proteins with a major role in antioxidative activity and regulatory
processes.
Conclusions: We have identified proteins that help protect against oxidative stress and are uniquely present in the
seminal plasma of the ROS- men. Men exhibiting high levels of ROS in their seminal ejaculate are likely to exhibit
proteins that are either downregulated or oxidatively modified, and these could potentially contribute to male
infertility.
Keywords: Seminal plasma, Male infertility, Varicocele, Reactive oxygen species, Oxidative stress, Proteomics,
Mass spectroscopy, Differentially expressed proteins, Gene ontologyBackground
The seminal plasma is composed of secretions from
accessory sex glands and is rich in sugars, lipids, pro-
teins, and other metabolites that interact with spermato-
zoa [1,2]. Many seminal plasma proteins can attach to
the surface of human spermatozoa and promote motility
and prevent premature acrosome reactions [3]. Similarly,
heparin binding proteins bind to the sperm surface dur-
ing ejaculation and form a protein coating [4]. These* Correspondence: agarwaa@ccf.org
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reproduction in any medium, provided the orfindings suggest that seminal plasma proteins play a role
in fertilization including capacitation, acrosome reaction
and oocyte interaction [5].
Advancements in mass spectrometry have aided in the
identification of seminal plasma proteins that regulate
sperm function. Improvements in proteomic approaches
including pre-fractionation of proteins, improved reso-
lution and high sensitivity of mass spectrometry tech-
niques have improved our understanding of the proteomic
composition of the seminal plasma [6]. Several techniques
have been used to identify the proteins of functional rele-
vance on a comparative basis. This includes the differential
in gel electrophoresis approach, which separates intactl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Sharma et al. Reproductive Biology and Endocrinology 2013, 11:85 Page 2 of 15
http://www.rbej.com/content/11/1/85proteins for quantitative analysis and identification by
mass spectrometry analysis. This method has been used to
compare the post-translational changes as well as changes
in the external sperm coat; synthesis and secretion of
some novel glycoproteins resulting in glycosylation and
modification of the surface charge etc. are taking place as
spermatozoa pass through the epididymal region [7]. The
top-down proteomics approach identifies large number of
peptides present in the sample; it is advantageous as pep-
tides show a lesser degree of variability than proteins and
thus form a reliable basis for proteomic comparisons [8].
Many of the proteomic analysis of bodily fluid such as the
seminal plasma have been done using liquid chromatog-
raphy tandem mass spectrometry (LC-MS/MS) measure-
ments [9]. Although this is a useful method, the accuracy
of mass measurement is low and the possibility of identify-
ing unambiguous proteins is high.
The recently developed linear ion trap (LTQ) coupled to
a Fourier transform ion cyclotron resonance analyzer has
been useful for its high sensitivity and fast sequencing cy-
cles with high mass accuracy and resolution [10]. Several
reports have identified the proteins of the seminal plasma,
and a repository has been developed. Fung et al. have
identified 100 proteins in the seminal plasma of normal
individuals utilizing 1-dimensional and 2-dimensional
electrophoresis methods coupled to both matrix assisted
laser desorption ionization-time of flight (MALDI-TOF)
mass spectrometry and liquid chromatography-tandem
mass spectrometry (LC-MS/MS) [11]. Similarly, Milardi
et al. identified about 1487 proteins in five fertile men
using high resolution LTQ-Orbitrap XL hybrid mass spec-
trometer [5].
Several comparative studies utilizing proteomic ap-
proaches have suggested that there are proteins in asthe-
nozoospermia patients that are not present in healthy men
[12] or in post varicocelectomy patients [13]. However, in-
formation on the unique proteins present in the seminal
plasma containing high levels of reactive oxygen species
(ROS) is lacking. Oxidative stress has been implicated in
the etiology of male infertility [14-21]. Identifying and un-
derstanding the proteins that play a key role in oxidative
stress-induced pathophysiology of male infertility is im-
portant as it can help in the development of some of these
key proteins as potential biomarkers.
In this study, we identified the differentially expressed
proteins in the seminal plasma of 1) infertile men who
were referred to our andrology clinical laboratory for
measurement of oxidative stress parameters such as
levels of ROS in spermatozoa, concentration of antioxi-
dant in the seminal plasma and the extent of DNA dam-
age 2) healthy men of unproven fertility exhibiting high
levels of ROS in their seminal ejaculates and 3) healthy
men of unproven fertility with low levels of ROS. We
employed LC-MS/MS techniques, and Bioinformaticsanalysis was performed to understand the roles of the
differentially expressed proteins in the seminal plasma of
ROS+ and ROS- subjects and their roles in various sig-
naling pathways. Together, the findings from this study
should provide a platform to better understand the
underlying pathology of oxidative stress in infertile men.
Methods
Following approval from the Institutional Review Board
(IRB) of Cleveland Clinic, we enrolled a total of 52 sub-
jects: 20 healthy male volunteers of unproven fertility
(men with normal semen analysis results but who had
not yet established a pregnancy) and 32 infertile men at-
tending our infertility clinic who were referred to the an-
drology lab for evaluation of oxidative stress parameters.
IRB consent approved by the Cleveland Clinic was pro-
vided to each subject, and the purpose of the study was
clearly explained. If the participant was interested, a
written signature was obtained and witnessed before he
was enrolled in the study.
Of the 32 patients, 25 (25 of 32; 78.1%) presented with
primary infertility and 7 (7 of 25; 28%) with secondary
infertility. 64% (16 of 25) had primary infertility of
≤2 years and 36% (9 of 25) >2 years. Clinical varicocele
(grade 1–2) was seen in 62.5% of patients with primary
infertility <2 years and in 55.6% with >2 years. In pa-
tients with secondary infertility, 85.7% of the patients
were identified with clinical varicocele (grade 1–2). Of
the 32 patients, only 10 subjects (10 of 32; 31.3%) had a
history of smoking.
Semen samples were collected by masturbation after 2–
3 days of sexual abstinence and analyzed according to
WHO 2010 criteria [22]. Semen analysis included both
macroscopic (volume, pH, color, viscosity, liquefaction
time, split or complete ejaculate) and microscopic parame-
ters (concentration, motility, morphology, round cells and
peroxidase or Endtz test). All infertile men were also ex-
amined for oxidative stress parameters such as levels of
ROS in the seminal ejaculate, total antioxidant concentra-
tion in the seminal plasma and extent of DNA damage in
the spermatozoa. Specimens that were positive for the
Endtz test (>1×106 white blood cells/ mL) indicative of an
underlying infection were not included in the study. Fol-
lowing these tests, the remaining seminal ejaculate was
frozen without any cryoprotectant and stored at −55°C for
proteomic analysis.
Semen analysis
After liquefaction, complete semen analysis was per-
formed to evaluate the sperm parameters (sperm count,
percentages motility and morphology), according to
WHO guidelines [22]. Semen analysis was done using a
MicroCell counting chamber (Vitrolife, San Diego, CA).
Smears of the raw semen were stained with a Diff-Quik
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IL) for assessment of sperm morphology according to
WHO criteria.
Measurement of reactive oxygen species
ROS levels were measured in seminal ejaculates by chemi-
luminescence assay using luminol (5-amino-2, 3- dihydro-1,
4-phthalazinedione; Sigma, St Louis, MO). Test samples
consisted of luminol (10 μL, 5 mM) and 400 μL of semen.
Negative controls were prepared by replacing the sperm
suspension with 400 μL phosphate buffered saline. Positive
control included 400 μL of PBS and 50 μL of hydrogen
peroxide (30%; 8.8 M) in triplicate. Chemiluminescence
was measured for 15 min using a Berthold luminometer
(Autolumat Plus 953). Results were expressed as relative
light units (RLU)/sec/ × 106 sperm [23,24].
Measurement of total antioxidant capacity
Total antioxidant capacity (TAC) was measured in the sem-
inal plasma samples using an antioxidant assay kit (Cayman
Chemical Company, Ann Arbor, MI) as described in our
earlier work [25]. Its principle is based on the ability of
aqueous- and lipid-based antioxidants in seminal plasma
to inhibit oxidation of the ABTS (2,2’-Azino-di-[3-
ethylbenzthiazoline sulphonate]) to ABTS•+. For the assay,
both standard (trolox) and sample (10 μL; 1:10 vol/ vol.)
was run in duplicate. 10 μL of metmyoglobin and 150 μL
of chromogen were added to each well. The reaction was
initiated by addition of 40 μL of hydrogen peroxide (work-
ing solution) using a multi-channel pipette as described
earlier [25]. The antioxidants present in the seminal plasma
suppress absorbance to a degree that is proportional to
their concentration. The measurement was read at 750 nm
using Microplate Reader (Epoch BioTek Gen 5 Absorb-
ance; BioTek Instruments, Inc., Winooski, VT). The results
were expressed as micromole trolox equivalents.
Sperm DNA fragmentation by terminal deoxynucleotidyl
transferase-mediated fluorescein-dUTP nick end labeling
(TUNEL) assay
Terminal deoxynucleotidyl transferase-mediated fluorescein-
dUTP nick end labeling (TUNEL) using the Apo-Direct™
kit (Pharmingen, San Diego, CA) was used to measure the
extent of DNA damage as described in earlier studies
[26,27]. Briefly, 1–2 million spermatozoa were resuspended
in 3.7% paraformaldehyde and re-suspended in 70% ice-
cold ethanol. Positive and negative kit controls as well
as internal controls (specimens from donors and pa-
tients with known DNA damage) were included for each
run. The staining solution contained terminal deoxytrans-
ferase (TdT) enzyme, TdT reaction buffer, fluorescein
isothiocynate tagged deoxyuridine triphosphate nucleotides
(FITC-dUTP) and distilled water. All specimens were fur-
ther washed in rinse buffer to remove the unbound reactionsolution, re-suspended in 0.5 mL of propidium iodide/
RNase solution, and incubated for 30 minutes in the dark
at room temperature followed by flow cytometric analysis.
All fluorescence signals of labeled spermatozoa were an-
alyzed by the flow cytometer FACScan (Becton Dickinson,
San Jose, CA). A total of 10,000 spermatozoa were exam-
ined for each assay at a flow rate of <100 cells/sec. The
excitation wavelength was 488 nm; green fluorescence
(480–530 nm) was measured in the FL-1 channel and red
fluorescence (580–630 nm) in the FL-2 channel using the
flow cytometer software FlowJo Mac version 8.2.4 (FlowJo,
LLC, Ashland, OR) [26,27].
Semen samples were divided into ROS+ and ROS-
groups. All samples were frozen at −55°C until the time
of analysis without addition of any cryoprotectant.
Trypsin digestion
For proteomic analysis, seminal plasma was separated
after cryopreservation. To prepare the samples for prote-
omic analysis, samples were thawed, and seminal plasma
was separated from the sperm pellet by centrifugation at
3,000 g for 30 minutes to ensure complete removal of
the cellular components. Seminal plasma samples were
pooled and dissolved in 98% acetonitrile containing 0.1%
trifluoroacetic acid followed by lyophilization at -80°C
under vacuum for 2 days. The lyophilized sample was used
to estimate the protein content. The samples were first
precipitated in cold acetone, solubilized in 6 M urea, re-
duced with dithiothreitol and alkylated with iodoacetamide.
The samples were subsequently diluted to give a urea
concentration <2 M and then digested with trypsin. The
tryptic digested products were subjected to a C18 clean up
and then brought up in 50 μL of 1% acetic acid.
Liquid chromatography- mass spectrometer analysis (LC-
MS-MS)
The LC-MS/MS system used in this study was a Finnigan
LTQ linear ion trap mass spectrometer. Ten μL volumes
of the extract were injected on a self-packed high perform-
ance liquid chromatography column (Phenomenex Jupiter
C18 reversed-phase capillary chromatography column).
Peptides were eluted from the column by an acetonitrile/
0.1% formic acid gradient at a flow rate of 0.25 μL/ min.
They were introduced into the source of the mass spec-
trometer on-line. The microelectrospray ion source was
operated at 2.5 kV. The digest was analyzed using the data
dependent multitask capability of the instrument acquir-
ing full scan mass spectra to determine peptide molecular
weights and product ion spectra to determine amino acid
sequence in successive instrument scans.
Data analysis
The data was analyzed using all collision-induced dis-
sociation spectra collected in the experiment to search
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(NCBI) human reference sequence database with the
search program MASCOT, a mass spectral search algo-
rithm that uses mass spectrometry data to identify pro-
teins from primary sequence databases. (Mascot version
2.7; Matrix Science, Boston, MA). These searches were
used to identify the proteins present in the in-solution
digestions. Following this, a second set of search was
performed with SEQUEST which is bundled into Prote-
ome (Discoverer 1.3; Thermo Finnigan), a tandem mass
spectrometry data analysis program used for protein
identification. Sequest identifies collections of tandem
mass spectra to peptide sequences that have been gener-
ated from databases of protein sequences. The results
from these SEQUEST searches were used to determine
the spectral counts. Normalization of the spectral count
was done using the total number of spectral counts for
all proteins in the sample and the number of amino
acids present in the protein. A 2-fold change in protein
expression was considered significant since the precision
of the proteomic analysis has an average error of 10-20%.
Functional bioinformatics analysis was done using pub-
licly available (Gene Ontology (GO) annotations from GO
Term Finder [28] and GO Term Mapper), UNIPROT
[29], STRAP [30], BioGPS [31] and proprietary software
packages such as Ingenuity Pathway Analysis (IPA from
Ingenuity® Systems), Metacore™ (GeneGo Inc.) and
STRING database [32] and Cytoscape [33] to identify the
differentially affected processes, pathways, cellular distri-
bution, and protein-protein interactions amongst proteins
in the two study groups as well as for data integration.
Pathway and network analysis
IPA and Metacore™ pathway databases were used to gain
a deeper understanding into the pathways, networks and
molecular and cellular functions affected in ROS+ and
ROS- groups. The NCBI accession number and/or gene
symbols were used as input identifiers for the analysis of
proteomic dataset using IPA and IPA reported top net-
works, pathways, and biological functions significant to
the protein dataset in terms of p-values and/or a score.
The significance of the association between the dataset
and the canonical pathway was measured by comparing
the number of specific proteins of interest that partici-
pate in a given pathway to the total number of occur-
rences of these genes in the dataset and the canonical
pathway is explained only by chance. The 'ratio' associ-
ated with each pathway indicates the percentage of pro-
teins in a pathway that were also found in our uploaded
proteins list. The IPA network Score (used to rank net-
works according to the degree of relevance to the net-
work eligible molecules in the user dataset) is based on
the hypergeometric distribution and is calculated with
the right-tailed Fisher's Exact Test.Similarly, the Metacore™ reported statistically signifi-
cant pathways, process or metabolic networks based on
false discovery rate (threshold of P<0.05). The dataset
was further subjected to identify protein functional net-
work analysis using STRING software that identified
both known and/or predicted interactions amongst the
proteins based on experimental and curated databases.
Results
Semen parameters and oxidative stress parameters
The results for semen parameters, ROS, TAC and DNA
damage is shown in Table 1. Sperm concentration
(×106/ mL) and percent motility in the controls was
69.49 ± 42.95 and 55.4% ± 14.0%, respectively, compared
to 42.93 ± 52.84 and 49.1% ± 16.4% in the infertile men.
Among the patients, 46.8% (15/32) had > 1 × 106 round
cells / mL compared to the donors 35% (7/ 20), and of
these, 16% were positive for the Endtz test, a marker for
granulocytes (the major contributor of ROS production).
None of the donors was positive for the Endtz test. An
overlap in morphology was seen in both donors (3.5% ±
1.6%) and infertile men (3.6% ± 3.2%).
Levels of ROS were elevated in many of the donors.
However, the levels were significantly lower (RLU/s/×106
sperm; Median (25th, 75th percentile) [4.4 (0, 300.2)] in
the donors compared with those in the infertile men
[104(0, 1341.0)]. Among the primary infertility patients
with <2 years of infertility, 80% were positive for ROS
versus 56% of the patients with >2 years of primary in-
fertility. Of those diagnosed with secondary infertility, a
significantly larger number of men had higher levels
(>20 RLU) of ROS. Teratozoospermia was present in
48% of men with primary infertility. Antioxidant and
DNA damage was measured only in the infertile group.
Antioxidant levels were low (<2000 micromoles of
trolox) in 48% of the men with primary infertility com-
pared with 57% in the men with secondary infertility. A
higher incidence of DNA damage (>19%) was seen in
28% of the infertile men with secondary infertility (up to
49% DNA damage) compared with 14% of the men with
primary infertility.
For proteomic analysis, all samples were categorized as
either ROS- i.e. <20 RLU/s/106sperm: median (Min,
Max) of 4.0 (0.0, 9.0) or 25th, 75th percentile of 0.0 (0.0,
0.0) and ROS+ with ROS levels significantly higher; me-
dian (Min, Max) of [22.4(33.0, 4439.0)] or median, 25th,
75th percentile of 503.8 (101.6, 1407.9). The two groups
were significantly different (P<0.01).
Identification of the proteins by mass spectrometry
We utilized LC-MS/MS to identify the proteins in sem-
inal plasma obtained from seminal ejaculates with high
levels of (ROS+) compared to those with normal levels
(ROS-). A total of 14 proteins were identified in these
Table 1 Semen parameters for donors, patients and ROS+ and ROS- samples
Parameter Donor (n = 20) Patients ROS- ROS+
(n = 32) (n = 20) (n = 32)
Sperm concentration 69.49 ± 42.95 42.93 ± 52.84 59.36 ± 45.61 43.51 ± 35.46
(×106/mL)
Motility (%) 55.4 ± 14.0 49.1 ± 16.4 51.6 ± 14.2 51.0 ± 16.7
Round cells (×106/mL) 2.92 ± 2.48 5.15 ± 2.37 2.40 ± 2.92 2.18 ± 2.10
Endtz (Myeloperoxidase positive) (×106/mL) 0.00 ± 0.00 0.00 ± 0.15 0.00 ± 0.00 0.10 ± 0.17
Morphology Kruger’s strict criteria (%) 3.5 ± 1.6 3.6 ± 3.2 3.2 ± 2.5 3.8 ± 2.8
ROS (RLU/sec/106 sperm) 2219.3 (0.0, 4438.5) 282.0 (0.0, 564.0) 4.0 (0.0, 9.0) 22.4 (33.0, 4439.0)
Median (Min., Max)
ROS (RLU/sec/106 sperm) 4.4 (0.0, 300.2) 104.0 (0.0, 1341.0) 0.0 (0.0, 0.0) 503.8 (101.6, 1407.9)
Median (25th, 75th percentile)
TAC (Micromole Trolox) - 2065.0 ± 5343.0 1994.0 ± 507.4 2011.0 ± 556.2
DNA (%) - 23.8 ± 10.9 18.0 ± 13.7 13.8 ± 9.4
ROS reactive oxygen species, RLU relative light unit.
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and ROS+ groups (Table 2). A comparison of the pro-
teins identified in the ROS+ and ROS- groups is given in
Table 3. Three proteins were uniquely expressed in the
ROS- group: fibronectin I isoform 3 preprotein/ fibro-
nectin 1 isoform b precursor, macrophage migration in-
hibitory factor-1 peptide and galectin 3 binding proteins.
There were 4 preproteins uniquely expressed in the
ROS+ group: cystatin S precursor, albumin preprotein,
lactotransferrin precursor-1 peptide and prostate specific
antigen isoform 4 preprotein were identified only in the
ROS+ group.Table 2 Proteins identified in LC-MS/MS from ROS- and ROS+
No. Protein name NCBI
database
index
number
C
1 semenogelin II precursor 4506885
2 semenogelin I isoform b preproprotein 38049014
3 fibronectin 1 isoform 3 preproprotein 16933542
4 prostate specific antigen isoform 1 preproprotein 4502173
5 clusterin isoform 1 42716297
6 macrophage migration inhibitory factor 4505185
7 prolactin-inducible protein precursor 4505821
8 galectin 3 binding protein 5031863
9 albumin preproprotein 4502027
10 cystatin S precursor 4503109
11 prostate specific antigen isoform 4 preproprotein 71834855
12 zinc alpha-2-glycoprotein 1 4502337
13 lactotransferrin precursor 54607120
14 acid phosphatase, prostate short isoform precursor 6382064The seven proteins that were commonly expressed
in both groups were: the prolactin induced protein,
semenogelin II precursor, acid phosphatase, prostate
short isoform precursor, clusterin preprotein, zinc alpha-
2-glycoprotein, prostate specific antigen isoform 1 pre-
protein and semenogelin I isoform (a preprotein). The
relative expression of these proteins was determined by
analysis of the spectral counts. This label free method
utilizes the number of spectra observed for each protein
as a measure of relative abundance. This type of analysis
is commonly used in proteomic experiments [26,27].
The normalized spectral count (NSC) ratios between theseminal plasma
alaculated
MW (kDa)
pI ROS- ROS+
Peptides Mascot Peptides Mascot
(Coverage) (Coverage)
65 9.0 9 (20%) 1968 7 (10%) 6998
45 9.2 6 (14%) 1597 3 (14%) 345
262 5.4 5 (3%) 964 - -
29 7.6 6 (38%) 486 3 (15%) 255
58 6.2 2 (3%) 233 4 (12%) 203
12 7.7 2 (9%) 206 - -
16 8.2 3 (48%) 123 5 (44%) 11771
66 5.1 1 (3%) 104 - -
71 5.9 - - 7 (17%) 1092
16 4.9 - - 2 (32%) 188
24 7.0 - - 2 (10%) 163
34 5.7 1 (7%) 125 2 (12%) 143
80 8.5 - - 1 (3%) 140
45 5.8 3 (8%) 220 3 (8%) 316
Table 3 Identification of proteins unique to ROS+ and ROS- groups and those common to both groups
Protein name Gene NCBI accession no. UniProt accession no. NSC ratio Log2 NSC ratio
fibronectin 1 isoform b precursor FN1 16933542 P02751 ROS- only
macrophage migration inhibitory factor-1 peptide MIF 4505185 P14174 ROS- only
galectin 3 binding protein LGALS3BP 5031863 Q08380 ROS- only
cystatin S precursor CST4 4503109 P01036 ROS+ only
albumin preprotein ALB 4502027 P02768 ROS+ only
lactotransferrin precursor-1 peptide LTF 54607120 P02788 ROS+ only
prostate specific antigen isoform 4 preprotein KLK3 71834855 P07288 ROS+ only
prolactin induced protein PIP 4505821 P12273 12.711 3.668
semenogelin II precursor SEMG2 4506885 Q02383 1.338 0.420
acid phosphatase, prostate short isoform precursor ACPP 6382064 P15309 1.063 0.088
clusterin preprotein CLU 355594753 P10909 0.753 −0.409
zinc alpha-2-glycoprotein 1 AZGP1 4502337 P25311 0.354 −1.498
prostate specific antigen isoform 1 preprotein KLK3 4502173 Q546G3 0.124 −3.012
semenogelin I isoform a preprotein SEMG1 4506883 P04279 0.032 −4.966
FN1 Fibronectin 1 isoform 3 preprotein, MIF macrophage migration inhibitory factor-1 peptide/factor protein, LGALS3BP Galectin-3 binding protein, CST4 cystatin
S-type 4, ALB Albumin, LTF Lactoferrin, KLK3 Prostate specific antigen, PIP Prolactin-inducing protein, SEMG2 Semenogelin-II, ACPP Prostatic acid phosphatase /
prostatic specific acid phosphatase, CLU Clusterin, AZGP1 Zinc-alpha-2-glycoprotein 1, SEMG1 Semenogelin-I.
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the NSC ratios are given in Table 3.
Upregulation (overexpressed) or downregulation (under-
expressed) of a protein was calculated from the Log2 NSC
ratio. Seven proteins were found to be differentially
expressed (Table 3). The upregulated proteins in the ROS+Figure 1 Functional annotation from consolidated publicly available s
ROS+ and ROS- group. Most proteins were localized in the extracellular reg
identified in ROS+ and ROS- group. Majority of the proteins were associate
seminal plasma proteins in ROS+ and ROS- group showing majority of thegroup included the prolactin-induced protein, semenogelin II
precursor and acid phosphatase and prostate short isoform
precursor. The proteins down regulated in the ROS- group
included the clusterin preprotein, Zinc alpha-2-glycoprotein
1, prostate specific antigen isoform I preprotein and
semenogelin I isoform a preprotein.oftware tools. (A): Cellular distribution of seminal plasma proteins in
ion (B): Biological processes distribution of seminal plasma proteins
d with protein regulation (C): Molecular function distribution of
protein with catalytic activity.
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ROS+ and ROS- samples
Gene ontology analyses were performed to establish the
link between cellular localization and biological processes
for all the proteins expressed commonly or uniquely in
the ROS+ and ROS- groups (Figure 1A-C). The cellular
distribution analyses showed that most proteins were lo-
calized in the extracellular region while a smaller propor-
tion of proteins originated from the plasma membrane
region (Figure 1A). Similarly, the distribution of proteins
in the biological processes showed a maximum involve-
ment in stress and regulatory responses (Figure 1B). Fur-
thermore, we were also able to show that most proteins
were involved in catalytic activity (Figure 1C).
A comparative analysis was done using GO annota-
tions to determine the distribution pattern of the pro-
teins identified in the three categories that were either
unique to ROS+ and ROS- groups or common to both.
A significant overlap in the functional categories was ob-
served for all the proteins in the ROS+, ROS- and com-
monly expressed groups. Among the unique proteins
expressed in ROS+ group, two were involved in protein-
aceous extracellular matrix (ECM) while the unique pro-
teins in the ROS- group were restricted to the vesicular
lumen region (Figure 2A).
The cellular distribution patterns revealed that most of
the commonly expressed proteins were extracellular in
origin (Figure 2A). Analysis of the biological processesFigure 2 Comparative analysis was done using GO annotations in 3 c
to both. (A): Among the cellular distribution of proteins the most commo
(B): Biological processes of proteins commonly expressed in both ROS- and R
to stress, cellular and metabolic processes and reproduction (C): Molecular funrevealed that the proteins commonly expressed in both
ROS- and ROS+ group were involved in major functions
such as the regulation, response to stress, cellular and
metabolic processes and reproduction (Figure 2B). The
unique proteins restricted to the ROS+ group revealed
that they were involved in cell morphogenesis, cell mo-
tility, cell cycle and aging; these proteins were absent in
ROS- group (Figure 2B).
Analysis of the molecular functions revealed that pro-
teins uniquely expressed in the ROS- groups were in-
volved in various enzymatic activities such as antioxidant
activity, DNA binding, enzyme regulation, peptidase and
serine hydrolase and serine endopeptidase activities; all
of these functions were diminished in the ROS+ group
(Figure 2C).
Pathways and network analysis of proteins
Ingenuity Pathway Analysis (IPA) and Metacore™ were
utilized to elucidate the biological pathways for proteins
unique or common to the ROS+ and ROS- groups. Can-
cer, diseases of the reproductive system, immunological
disease and inflammatory response were the top diseases
or disorders. The molecular and cellular functions asso-
ciated with the ROS- and ROS+ groups were cellular
development, cellular growth and proliferation, cellular
movement, cell-to-cell interaction and gene expression.
Hair and skin development, development and function
of the hematological system, immune cell trafficking,ategories either unique to ROS+ and ROS- groups or common
nly expressed in ROS+ and ROS- groups were extracellular in origin
OS+ group involved in major functions such as the regulation, response
ctions of proteins that were common was involved in catalytic activity.
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the highly represented physiological and functional pro-
cesses. The significant canonical pathways identified in
our study are shown in Table 4.
Fourteen proteins were analyzed with IPA software to
identify the significant pathways and interaction networks.
The top and the only network generated (with a network
score of 14) was composed of 35 nodes (genes/proteins),
only 6 of which were observed in our dataset of seminal
plasma proteins (Figure 3). SEMG2 (Semenogelin-II) and
CLU (Clusterin) proteins were significantly (2 fold) changed
(up or down- regulated) in the ROS+ compared to the
ROS- groups. FN1 (Fibronectin 1 isoform 3 preprotein)
and MIF (macrophage migration inhibitory factor-1 pep-
tide) were observed only in the ROS- group and LTF
(Lactoferrin) was present only in ROS+ group. KLK3 (Pros-
tate specific antigen) was observed in both the ROS+ and
ROS- group. The common protein that connected 5 out of
these 6 proteins was Ubiquitin C which is involved in con-
jugation and degradation of proteins impacting major pro-
cesses and functions. The top functions of the network
were cellular movement, cell-to-cell signaling and inter-
action, and infectious disease (Figure 4).
The Metacore analysis revealed the top pathways,
process and regulatory networks for proteins that were
common or unique to ROS+ and ROS- groups—theseTable 4 Significant canonical pathways associated with semin
Ingenuity Canonical Pathways
Eumelanin Biosynthesis
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Ar
Intrinsic Prothrombin Activation Pathway
MSP-RON Signaling Pathway
MIF-mediated Glucocorticoid Regulation
MIF Regulation of Innate Immunity
Thyroid Cancer Signaling
Neurotrophin/TRK Signaling
Atherosclerosis Signaling
Prostate Cancer Signaling
LXR/RXR Activation
Human Embryonic Stem Cell Pluripotency
IL-12 Signaling and Production in Macrophages
Hepatic Fibrosis / Hepatic Stellate Cell Activation
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages
Acute Phase Response Signaling
Clathrin-mediated Endocytosis Signaling
ILK Signaling
Actin Cytoskeleton Signaling
Pathways associated with proteins specific to ROS- group are in bold. MSP-RON Macrop
migration inhibitory factor, TRK Tyrosine kinase, LXR/RXR Liver X receptor / retinoid X re
FN1 Fibronectin 1 isoform 3 preprotein.are shown in Table 5 and Figure 4A. Further, STRING
database was used to identify any known or predicted dir-
ect interactions amongst these seminal proteins. The
STRING database identified interactions between eight
proteins (KLK3, SEMG1, SEMG2, FN1, LGALS3BP, ALB,
PIP, and AZGP1) based on experimental evidence. How-
ever PIP and AZGP1 did not interact with the remaining
six proteins. Five proteins known to be regulated by an-
drogen receptor were identified through Metacore analysis
(Figure 4B). The top GO processes identified for this net-
work were male somatic sex determination, activation of
prostrate induction by androgen receptor signaling path-
way and negative regulation of integrin biosynthesis
process (Figure 4C). The known direct interaction net-
work amongst the proteins as evidenced by the three soft-
ware packages, IPA, Metacore, and STRING, is shown in
Figure 4C.
Discussion
Although an increasing number of studies have identi-
fied more than 2545 unique proteins expressed in sem-
inal plasma very few seminal plasma proteins have been
unambiguously linked to infertility [34-36]. The role of
ROS and its effect on the seminal plasma proteins has
not been conclusively determined. A report by Wang
et al., showed down regulation of certain proteins in theal plasma
Ratio Proteins
5E-01 MIF
thritis 1.35E-02 MIF, FN1
8.33E-02 KLK3
5.88E-02 KLK3
4.76E-02 MIF
4E-02 MIF
3.57E-02 KLK3
2.5E-02 KLK3
1.89E-02 CLU
1.79E-02 KLK3
1.56E-02 CLU
1.56E-02 KLK3
1.54E-02 CLU
1.2E-02 FN1
1.11E-02 CLU
1.06E-02 FN1
1.06E-02 CLU
1.05E-02 FN1
9.01E-03 FN1
hage-stimulating protein- transmembrane receptor kinase, MIF Macrophage
ceptor, IL Interleukin, KLK3 Prostate specific antigen, CLU Clusterin,
Figure 3 IPA generated network for seminal plasma proteins showing 6 focus molecules highlighted in bold. KLK3 = Prostate specific
antigen; SEMG2 = Semenogelin-II; FN1 = Fibronectin 1 isoform 3 preprotein; LTF = Lactoferrin; MIF = macrophage migration inhibitory factor-1
peptide/factor protein and CLU = Clusterin.
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sult of oxidative stress, and attributed it to infection and
environmental factors [12]. In the current study we uti-
lized a combination of proteomic tools such as the LC-
MS/MS and database searches to identify the proteins
and the potential pathways/ networks that might be rele-
vant to oxidative stress induced sperm dysfunction.
MS identification of the proteins
We used two different search engines to decrease the
amount of false positive protein identification and quanti-
tative results. The utilization of multiple search engines is
fairly common place and has been shown to improve the
reproducibility and sensitivity of proteomic experiments
[37]. Furthermore, the utilization of multiple search en-
gines in these experiments was performed to verify the
spectral count information and the proteins listed as
quantitatively different were validated by both search en-
gines. The searches were redone with newer versions of
both Mascot and Sequest and the same proteins were
identified in both searches eliminating any differences in
the results. Biological replicates are important in these
types of experiments. Therefore, the samples from 32 in-
fertile men and 20 normal donors were characterized aseither ROS- or ROS+ and pooled prior to digestion and
LC-MS/MS analysis. The LC-MS/MS analysis was only
carried out once and therefore no p-values were assigned.
These experiments were analyzed with only one LC-MS
analysis with the strategy that follow up validation experi-
ments would be performed on additional biological repli-
cates that would verify the LC-MS results.
Three of the important proteins - FN1 (Fibronectin 1
isoform 3 preprotein), macrophage migration inhibitory
factor protein (MIF) and Galectin 3 binding protein
(G3BP)-were solely expressed in the ROS- group and
were distinctly absent in ROS+ group. Fibronectin is a
ubiquitous multifunctional glycoprotein and a compo-
nent of the seminal fluid and plays a key role in the for-
mation of seminal gel following ejaculation [38]. It can
bind to cellular components that are exposed when a
spermatozoa is damaged and thus helps select abnormal
spermatozoa [39]. While our studies reported the pres-
ence of fibronectin only in the ROS- groups, Davalieva
et al. reported increased expression of fibronectin in
azoospermic patients when compared with normozoo-
spermic men [40].
MIF is a secretory protein of the epididymis that has
a catalytic property. It maintains the thiol protein
Figure 4 Known or predicted protein-protein interaction network for seminal plasma proteins, A: 8 of 14 proteins interactions
identified by STRING analyses were based on ‘experimental evidence’ and/or ‘curated pathway databases’. B. Five proteins regulated
by androgen receptor were identified through Metacore analysis; red shaded circles = upregulated proteins; blue circle = downregulated
proteins, the shaded indicates the intensity of the regulation, C: Consolidated direct interaction network evidenced from 3 data sources (IPA,
Metacore and STRING) showing that amongst 12 of 14 proteins, the central players were FN1, KLK3, and AR, all of which are connected to the
majority of these proteins.
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ences their motility [41]. G3BP belongs to a family of
galectin β-galactoside-binding proteins and is involved
in immunomodulation, cell-cell and cell-matrix adhe-
sion, and pathogen-host interactions [42]. Compared to
the studies of Davalieva et al., G3BP was found to be
upregulated in oligozoospermic patients [38]. Although
it is a substrate for prostate specific antigen, reports on
the functioning of G3BP in male infertility are lacking
[43]. The proteins unique to the ROS+ group included
the cystatin S precursor, albumin preprotein, lacto-
transferrin precursor-1 peptide and prostate specific an-
tigen isoform 4 preprotein. Interestingly, most of the
proteins identified as being unique to the ROS+ group
represent proteins that are present in their precursor
form, and are most likely indicative of post-translational
problems [44].Lactotransferrin is an important transport protein
that has antimicrobial properties and forms sperm
coating antigen whereas albumin functions as a reser-
voir for cholesterol. Albumin must be removed from
the sperm membrane during capacitation [4,45].
Cystatins are known to control the activity of cysteine
proteases and thus, they exist in several isoforms [4].
Amongst the various differentially regulated proteins
identified, the two isoforms of semenogelin showed a
contrasting expression, i.e. semenogelin II precursor
was found to be similar in expression while the
semenogelin I isoform--a preprotein-was found to be
down regulated in the ROS+ group compared with
the ROS- group. This result differs from that of an-
other study that found no significant differences be-
tween the two isoforms of semenogelin I and II in
asthenozoospermic groups compared to healthy
Table 5 Significant pathways, networks and processes
identified from Metacore analysis of seminal plasma
proteins
Metacore pathways Proteins (from our dataset)
associated with the category
Protein folding and maturation KLK3
Immune response CLU
Androgen receptor signaling KLK3
Extracellular matrix remodeling
(ECM)
KLK3
ATP/ Ionisitol triphosphate
metabolism
ACPP
Metacore process networks
Reproduction KLK3, CLU
Proteolysis ECM remodeling KLK3, CLU
Proteolysis connective tissue
degradation
KLK3
Inflammation CLU
Signal transduction PIP, KLK3
Reproduction feeding and
neurohormone signaling
PIP
Immune response antigen
presentation
AZGP1
Regulation of angiogenesis CLU
Metabolic network
Alpha-L-fucosyl (1–2)-D-
galactose pathway
KLK3, SEMG1, SEMG2
Phosphatidylethanolamine
pathway
KLK3
2-arachidonoyl-glycerol 3-
phosphocholine pathway
KLK3
Lipid metabolism phospholipid
metabolism
ACPP
Biological processes
Insemination SEMG1, KLK3
Liquefaction of seminal ejaculate KLK3
Reproduction KLK3, CLU, SEMG1, SEMG2
KLK3 Prostate specific antigen, CLU Clusterin, ACPP Prostatic acid phosphatase /
prostatic specific acid phosphatase, PIP Prolactin-inducing protein, AZGP1 Zinc-
alpha-2-glycoprotein, SEMG1 Semenogelin-I, SEMG2 Semenogelin-II.
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ever, the overexpression of both semenogelin I and II
was reported in post-varicocelectomy patients largely
due to oxidative stress [46].
Another striking finding of our study was the high
abundance of prolactin induced protein (PIP) in the
ROS+ group. Seminal plasma is known to have
immunomodulating properties [47-49]. While no asso-
ciation was reported between the levels of total immu-
noreactive PIP in the seminal plasma and the fertility
rate [50], contradictory results were seen in the sem-
inal plasma proteome from azoospermic men [51] andin the sperm proteome from globozoospermic and
asthenozoospermic men [44,52]. Similarly, PIP expres-
sion was increased in the azoospermic group com-
pared to the oligozoospermic group and thus, PIP
could serve as a potential biomarker in these cases
[40]. Increased presence of PIP in human spermatozoa
has been correlated with poor sperm quality [53].
Prostate specific antigen preprotein was restricted to
the ROS+ group; the isoform 1 preprotein was
downregulated in the ROS+ group compared to ROS-
group.GO annotation analysis of the MS identified proteins
All the proteins identified in the study were subjected
to GO analysis, which revealed a large overlap of pro-
teins in the cellular localizations, and biological and
molecular functions of the proteins. This phenomenon
of protein overlap in GO analysis of seminal plasma
has also been identified by various other researchers,
indicating that proteins in the seminal plasma are in-
volved in multiple functions [5,12,54,55]. The GO an-
notation analysis showed a greater distribution of
proteins with extracellular and cytoplasmic origin. Fur-
thermore, intracellular organelles, secretory granules
and vesicles also showed a similar distribution of pro-
teins in both the ROS+ and ROS- group (Figure 1A).
In the biological processes, regulation followed by stress
response and interaction with the cells was observed (Fig-
ure 1B), suggesting that seminal plasma proteins regulate
spermatogenesis and spermatozoa as they transit through
the epididymis [56]. Among the molecular processes, a
major distribution was seen in the catalytic activity, which
indicates that the major proteins are involved in proteo-
lytic cleavage (Figure 1C).
Cysteine proteases belong to a group of proteases that
are involved in various regulatory mechanisms such as
intracellular catabolism of peptides and proteins [57] pro-
cessing of proenzymes and prohormones [58-60]. Cysteine
proteases play a modulatory role in the proliferation and
destruction of tissues by malignant cells during tumor in-
vasion and metastasis [60] and by microorganisms during
infection [61]. Cystatins act as inhibitors and protect the
host tissues against destructive proteolysis [62]. Molecular
functions also reveal a great deal of binding activity. Gly-
cosaminoglycans such as the heparin binding proteins
(HBPs) of the seminal fluid have been reported to attach
to the sperm surface and enhance capacitation. Several
heparin binding proteins in the seminal plasma have been
characterized and alterations in these proteins have been
shown to result in male infertility [4]. In our study lac-
toferrin, isoforms of semenogelin and prostate specific
antigen precursor were similar to the many proteins char-
acterized for heparin binding.
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identified in ROS+ and ROS - groups
The cellular distribution pattern revealed that besides
the common proteins, which were abundant in the
extracellular region, the unique proteins of the ROS+
group were involved in extracellular matrix (ECM) for-
mation while those of the ROS- group were in vesicle
lumen (Figure 2A). This finding suggests that the
unique proteins of the ROS- group assist in the process
of endocytosis, which is diminished in the ROS+ group
and making it more susceptible to infection and other
inflammatory responses. Prostate specific antigen (KLK3)
is known to be involved in ECM remodeling. In our
study, two isoforms of KLK3 were observed; one was
restricted to the ROS+ group whereas the other form
was downregulated in the ROS+ group. However, both
isoforms were present in preprotein forms, which is
most likely caused by an improper post-translational
process leading to an improper formation of the ECM
complex. The comparative distribution of proteins in
biological processes involved with ageing, cell cycle, cell
differentiation and morphogenesis, motility and loco-
motion were seen only in the ROS+ group, suggesting
that these functions may be involved in sperm inter-
action and therefore may play a role in sperm apoptosis,
necrosis and cell death (Figure 2B).
The distribution pattern of molecular functions revealed
that the common proteins had a high degree of involvement
in catalytic activity. MIF is known for its catalytic property,
which maintains the thiol redox status in spermatozoa. During
epididymal transit, the histones in a mature spermatozoon are
replaced with thiol groups to aid in the tight packaging of
chromatin material. Its absence in the ROS+ groups indicates
improper packaging of chromatin and thus DNA damage.
Our study revealed an important prostasome in the
ROS- group, the Galectin-3 binding protein (LGALS3BP)
which could represent an important candidate biomarker
of reproduction and prostate cancer. Interestingly, while
LGALS3BP was only restricted to the ROS- group, the
semenogelin I and PIP proteins were differentially ex-
pressed. This is indicative of an improper binding regula-
tory activity [63].Pathway and network analysis of the identified proteins
in ROS+ and ROS- groups
The IPA figure was generated to identify the indirect
interactions or the shortest path that connects the
proteins of our interest. The Metacore network was
generated to identify the co-regulators or shared tran-
scriptional regulators of the genes encoded by the
proteins of our interest. Since there were a significant
number of proteins regulated by androgen receptor
(AR), the STRING network was generated to find outif any and which of these proteins directly interact
with each other.
We chose to conduct multiple network analyses to
accomplish different outcomes individualized for the
respective questions we wanted to address. If we had
merged the three networks as is into one, we would
have compromised the clarity of figures; and missed
on the elaboration of certain aspects of the network
such as other interacting proteins (in the IPA figure)
that were not observed in our samples, but are
known to interact with our list of proteins and affect
certain processes/functions. IPA pathway analysis of
the commonly and differentially expressed proteins
revealed that extracellular matrix proteins such as fi-
bronectin were involved in the ILK (Integrin linked
kinase) pathway. The binding of the fibronectin pep-
tide could augment integrin signaling [64,65] during
fertilization. Furthermore, Ingenuity Canonical Path-
way (ICP) analysis showed that FN1 was involved in
ILK signaling in the ROS- group and that this process
may have been absent in the ROS+ group due to the
absence of fibronectin. The shortest path connecting
the majority of the proteins was through ubiquitin C,
to which 5 out of the 6 proteins were known to bind
(Figure 3).
Metacore™ analysis shows that KLK3 is a key protein
that is involved in a majority of pathways, processes and
networks. We have demonstrated important networks
such as reproduction, proteolysis in remodeling of
extracellular matrix, proteolysis in degradation of con-
nective tissue and signal transduction. The metabolic
networks that include KLK3 are alpha-fucosyl (1–2)-D
galactose pathway, phosphatidylethanolamine pathway,
2-arachidonoyl-glycerol 3 phosphocholine pathway. The
biological processes include insemination and seminal
clot liquefaction. KLK3 or prostate specific antigen is
secreted from the prostate secretion, and may play a
role as a biomarker in prostate cancer [11].
Isoform 4 preprotein was specific to the ROS+ group
only while the isoform 1 preprotein was downregulated
in this group compared to ROS- group. It is likely that
oxidative stress biomarkers can also be conceivably use-
ful in identifying the underlying cause(s) of prostate can-
cer as it has been shown to exist in five different forms
and 1 truncated form and hence, the lack of its specifi-
city as a unique biomarker [11,66,67].
We also studied the interactions between the identified
proteins using STRING software. We found that KLK3
regulated SEMG1 and SEMG2 as well as FN1. KLK3 was
restricted only to the ROS+ group, suggesting improper
cleavage of semenogelin and fibronectin and subsequent
problems with liquefaction and hyperviscosity in this
group [68,69]. Contrary to reports of Kumar et al., [70]
who examined the interaction between human serum
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interaction between albumin preprotein and PIP.
Our study through Metacore™ analysis also identified five
genes that are transcriptionally regulated by the androgen
receptor: AZGP1, Clusterin, KLK3, PIP and ACPP. Further
analysis showed that these signaling pathways were not
only involved in the activation of prostate induction but
also in male somatic sex determination and negative regu-
lation of the integrin biosynthetic process. Our consoli-
dated direct interaction network (Figure 4C) amongst 12
of 14 proteins shows the central players as FN1, KLK3, and
AR, all of which are connected to the majority of these
proteins. The integrated seminal plasma protein direct
interactome network of seminal plasma proteins in ROS+
and/or ROS- samples obtained from three data sources,
(IPA, Metacore, and STRING) is shown in Figure 4C. FN1
interacts with 4 proteins - LGALS3BP, ALB, KLK3, and
CLU interactions that are experimentally validated as per
the STRING database and LTF and KLK3 interactions
from IPA are evidenced from the literature curation efforts.
The interactions shown by Metacore are the proteins
(ACPP, AZGP1, CLU, KLK3, and PIP) encoded by genes
that are regulated by androgen receptor. KLK3 also inter-
acts with SEMG I, SEMG II, and FN1.
There were some limitations to our study. One of the
possible drawbacks of our study was that we did not com-
pletely eliminate the presence of round cells (possible ex-
trinsic source of ROS production in these samples).
Round cells especially the granulocytes are significant con-
tributors of ROS in the seminal ejaculate. We did not look
into other information such as patient’s age/ethnicity,
pharmacological treatments and medical status as our pri-
mary focus was to examine the effect of high and physio-
logical levels of ROS on protein distribution irrespective
of other criteria. Another limitation was the small number
of proteins identified in the ROS+ and ROS- groups. This
may have occurred due to masking of the low abundant
proteins by the high abundant proteins--proteomic
methods based on LC-MS/MS do not identify all biologic-
ally relevant components and they exclude analysis of in-
tact proteins. Revalidation of the results by quantitative
western immunoblot analysis of sperm extracts with spe-
cific antibodies is important. This was a pilot study for
proof of concept. We plan to perform the immunoblot in
our ongoing series of investigations.
Conclusions
In conclusion, it is evident that proteomic analysis of sem-
inal plasma has potential clinical implications. We have
established the presence of several proteins including fi-
bronectin and prostate specific antigen and PIP in seminal
plasma with both low and high levels of ROS. The prote-
omic approach utilized in our study employing various
bioinformatic tools revealed the cellular pathways that areinvolved in oxidative stress that could serve as biomarkers
in identifying non-invasive diagnostic tools for various re-
productive disorders. The relatively high abundance of
PIP proteins needs to be further validated through West-
ern Blot analysis as a possible biomarker for male infertil-
ity. It is important to understand the proteins involved in
oxidative stress and inflammation because this will help
identify any drugs and antioxidant therapies that could
help treat infertile men with oxidative stress-related
infertility.
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